-The Business Standard NPPA to soon notify prices in line with new pharma pricing policy Some key cancer drugs, antibiotics and medicines to treat cardiovascular diseases and tuberculosis are set to become cheaper by up to 50 per cent within the next 45 days. The National Pharmaceutical Pricing Authority (NPPA) will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according...

-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans...

-The Hindustan Times Bhopal: Now death audit of every patient who dies in a government hospital would be carried out. The health department's move will help to ascertain the cause of death of the patient. Another reason behind conducting the death audit is to monitor whether there was any negligence in treating the patient. Director, health, Dr KK Thassu said all chief medical and health officers (CMHOs) were instructed to conduct death...

-PTI Purulia: Thirteen infants have died at the Purulia Sadar Deben Mahato Hospital in Purulia since last Friday, the hospital said on Monday. Most of the infants were in the age group of 0-11 months, hospital superintendent Nilanjana Sen said. While eight deaths were reported on Friday, three infants died on Saturday and two deaths were reported on Sunday, she added. The infants, who were brought to the Sadar hospital from the block-level...

-The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material". The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening...